Reclassification of gabapentin and pregabalin as CDs (March 2019)

Reclassification of gabapentin and pregabalin as CDs (March 2019)

February 14, 2019

This briefing has been compiled to support community pharmacy teams as the reclassification of pregabalin and gabapentin as Schedule 3 Controlled Drugs (CDs) comes into force on 1st April 2019

PSNC Briefing 010/19: Reclassification of gabapentin and pregabalin as CDs (revised 01/04/2019)

If you have any queries on this PSNC Briefing or you require more information, please contact the Dispensing & Supply Team.

To browse other PSNC briefings on dispensing and supply click here.

View Article…



Posted in:


More Latest News >

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...